CFLAR and neoplasm: Overcoming intracellular inhibiting factors, such as FLIP, is another option to sensitise tumour cells to TRAIL-mediated apoptosis, especially in cells impaired in drug-induced upregulation of TRAIL receptors on the cell surface.